AI in drug safety monitoring
In the realm of healthcare, ensuring the safety and efficacy of medications is paramount to protecting public health and improving patient outcomes. However, traditional methods of drug safety monitoring, such as spontaneous reporting systems and clinical trials, have limitations in detecting and characterizing adverse drug reactions (ADRs) in real-world settings. To address these challenges, the
